Section
Deals
M&A, licensing, and major transactions shaping the industry
DealsFiercePharma ↗
With Daiichi Sankyo’s priorities increasingly tied to its innovative medicines—and its oncology portfolio in p…
DealsBriefing
UCB’s $650M-plus purchase of Neurona Therapeutics signals a move beyond small molecules into regenerative neur…
DealsBriefing
Novo Nordisk unveiled a global AI collaboration with OpenAI, extending from drug discovery to manufacturing as…
Deals
Aligos sells Greater China rights to its phase 2 HBV drug for $25M upfront and up to $420M in milestones, as A…
DealsEndpoints News ↗
Biovac’s new vaccine factory in Cape Town, which is expected to make up to 400 million vaccines per year, has …
DealsPharmaceutical Technology ↗
Daiichi Sankyo has partnered with Interna Therapeutics to develop targeted delivery solutions based on molecul…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.